These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 60073)

  • 21. Kinetics of the reduction in viability of cultured L1210 leukemia cells exposed to 5-azacytidine (NSC-102816).
    Lloyd HH; Dulmadge EA; Wilkoff LJ
    Cancer Chemother Rep; 1972 Oct; 56(5):585-91. PubMed ID: 4119906
    [No Abstract]   [Full Text] [Related]  

  • 22. [Attempt at treatment of acute leukemias with cytosine-arabinoside according to Skipper's method].
    Schwarzenberg L; Mathé G; Hayat M; de Vassal F; Amiel JL; Cattan A; Schneider M; Schlumberger JR; Rosenfeld C; Jasmin C
    Nouv Rev Fr Hematol; 1969; 9(2):199-204. PubMed ID: 4239783
    [No Abstract]   [Full Text] [Related]  

  • 23. Continuous infusion of 5-azacytidine as induction for acute nonlymphocytic leukemia in patients with previous exposure to 5-azacytidine.
    Gaynon PS; Baum ES
    Oncology; 1983; 40(3):192-4. PubMed ID: 6189042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative studies of the cytostatic action and metabolism of 5-azacytidine and 5,6-dihydro-5-azacytidine.
    Voytek P; Beisler JA; Abbasi MM; Wolpert-DeFilippes MK
    Cancer Res; 1977 Jul; 37(7 Pt 1):1956-61. PubMed ID: 67884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maintenance treatment with azacytidine for patients with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy.
    Grövdal M; Karimi M; Khan R; Aggerholm A; Antunovic P; Astermark J; Bernell P; Engström LM; Kjeldsen L; Linder O; Nilsson L; Olsson A; Holm MS; Tangen JM; Wallvik J; Oberg G; Hokland P; Jacobsen SE; Porwit A; Hellström-Lindberg E
    Br J Haematol; 2010 Aug; 150(3):293-302. PubMed ID: 20497178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia.
    Lainey E; Wolfromm A; Marie N; Enot D; Scoazec M; Bouteloup C; Leroy C; Micol JB; De Botton S; Galluzzi L; Fenaux P; Kroemer G
    Oncogene; 2013 Sep; 32(37):4331-42. PubMed ID: 23085751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tallimustine, an effective antileukemic agent in a severe combined immunodeficient mouse model of adult myelogenous leukemia, induces remissions in a phase I study.
    Beran M; Jeha S; O'Brien S; Estey E; Vitek L; Zurlo MG; Rios MB; Keating M; Kantarjian H
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2377-84. PubMed ID: 9815637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Twice weekly 5-azacytidine infusion in dissmeinated metastatic cancer: a phase II study.
    Vélez-Garcia E; Vogler WR; Bartolucci AA; Arkun SN
    Cancer Treat Rep; 1977 Dec; 61(9):1675-7. PubMed ID: 74283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II evaluation of aclarubicin in refractory adult acute leukemia: a Southwest Oncology Group Study.
    Dabich L; Bull FE; Beltran G; Athens JW; Coltman CA; Weick JK; Van Slyck EJ; Amare M
    Cancer Treat Rep; 1986 Aug; 70(8):967-9. PubMed ID: 3460700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of human equilibrative nucleoside transporter 1 on the cellular transport of the DNA methyltransferase inhibitors 5-azacytidine and CP-4200 in human leukemia cells.
    Hummel-Eisenbeiss J; Hascher A; Hals PA; Sandvold ML; Müller-Tidow C; Lyko F; Rius M
    Mol Pharmacol; 2013 Sep; 84(3):438-50. PubMed ID: 23814180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study.
    DiNardo CD; Pratz KW; Letai A; Jonas BA; Wei AH; Thirman M; Arellano M; Frattini MG; Kantarjian H; Popovic R; Chyla B; Xu T; Dunbar M; Agarwal SK; Humerickhouse R; Mabry M; Potluri J; Konopleva M; Pollyea DA
    Lancet Oncol; 2018 Feb; 19(2):216-228. PubMed ID: 29339097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low dose 5-azacytidine is ineffective for remission induction in patients with acute myeloid leukemia.
    Lee EJ; Hogge DE; Gallagher R; Schiffer CA
    Leukemia; 1990 Dec; 4(12):835-8. PubMed ID: 1700839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatotoxicity of 5-azacytidine (NSC-102816) (a clinical and pathologic study).
    Bellet RE; Mastrangelo MJ; Engstrom PF; Custer RP
    Neoplasma; 1973; 20(3):303-9. PubMed ID: 4125219
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical study of daunomycin and prednisone for induction of remission in children with advanced leukemia.
    Holton CP; Vietti TJ; Nora AH; Donaldson MH; Stuckey WJ; Watkins WL; Lane DM
    N Engl J Med; 1969 Jan; 280(4):171-4. PubMed ID: 5248383
    [No Abstract]   [Full Text] [Related]  

  • 35. Antitumor activity of pyrazofurin in combination with 5-azacytidine against murine P388 and L1210 leukemias and colon carcinoma 26.
    Chiuten DF; Muggia FM; Johnson RK
    Cancer Treat Rep; 1979; 63(11-12):1857-62. PubMed ID: 93512
    [No Abstract]   [Full Text] [Related]  

  • 36. Contrasting cytotoxicity kinetics of 5-azacytidine and dihydro-5-azacytidine hydrochloride in L1210 leukemia in mice.
    Presant CA; Coulter D; Valeriote F; Vietti TJ
    J Natl Cancer Inst; 1981 Jun; 66(6):1151-4. PubMed ID: 6165854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-Azacytidine in the Treatment of Intermediate-2 and High-risk Myelodysplastic Syndromes and Acute Myeloid Leukemia. A Five-year Experience with 44 Consecutive Patients.
    Diamantopoulos P; Zervakis K; Papadopoulou V; Iliakis T; Kalala F; Giannakopoulou N; Rougala N; Galanopoulos A; Bakarakos P; Variami E; Dimitrakopoulou A; Viniou NA
    Anticancer Res; 2015 Sep; 35(9):5141-7. PubMed ID: 26254419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-azacytidine enhances efficacy of multiple chemotherapy drugs in AML and lung cancer with modulation of CpG methylation.
    Füller M; Klein M; Schmidt E; Rohde C; Göllner S; Schulze I; Qianli J; Berdel WE; Edemir B; Müller-Tidow C; Tschanter P
    Int J Oncol; 2015 Mar; 46(3):1192-204. PubMed ID: 25501798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-Azacytidine/5-Azacitidine.
    Müller AM; Florek M
    Recent Results Cancer Res; 2014; 201():299-324. PubMed ID: 24756801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The chemotherapy of human and animal acute leukemia.
    Goldin A; Sandberg JS; Henderson ES; Newman JW; Frei E; Holland JF
    Cancer Chemother Rep; 1971 Nov; 55(4):309-505. PubMed ID: 4945857
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.